Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-04-01
|
| Series: | Blood Cancer Journal |
| Online Access: | https://doi.org/10.1038/s41408-025-01258-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850217158522437632 |
|---|---|
| author | Fieke W. Hoff Ying Huang Rina Li Welkie Ronan T. Swords Elie Traer Eytan M. Stein Tara L. Lin Prapti A. Patel Robert H. Collins Maria R. Baer Vu H. Duong William G. Blum Martha L. Arellano Wendy Stock Olatoyosi Odenike Robert L. Redner Tibor Kovacsovics Michael W. Deininger Joshua F. Zeidner Rebecca L. Olin Catherine C. Smith James M. Foran Gary J. Schiller Emily K. Curran Kristin L. Koenig Nyla A. Heerema Timothy Chen Molly Martycz Mona Stefanos Sonja G. Marcus Leonard Rosenberg Brian J. Druker Ross L. Levine Amy Burd Ashley O. Yocum Uma M. Borate Alice S. Mims John C. Byrd Yazan F. Madanat |
| author_facet | Fieke W. Hoff Ying Huang Rina Li Welkie Ronan T. Swords Elie Traer Eytan M. Stein Tara L. Lin Prapti A. Patel Robert H. Collins Maria R. Baer Vu H. Duong William G. Blum Martha L. Arellano Wendy Stock Olatoyosi Odenike Robert L. Redner Tibor Kovacsovics Michael W. Deininger Joshua F. Zeidner Rebecca L. Olin Catherine C. Smith James M. Foran Gary J. Schiller Emily K. Curran Kristin L. Koenig Nyla A. Heerema Timothy Chen Molly Martycz Mona Stefanos Sonja G. Marcus Leonard Rosenberg Brian J. Druker Ross L. Levine Amy Burd Ashley O. Yocum Uma M. Borate Alice S. Mims John C. Byrd Yazan F. Madanat |
| author_sort | Fieke W. Hoff |
| collection | DOAJ |
| format | Article |
| id | doaj-art-a44c657328db4a71bfcdae3dd84400a1 |
| institution | OA Journals |
| issn | 2044-5385 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Nature Publishing Group |
| record_format | Article |
| series | Blood Cancer Journal |
| spelling | doaj-art-a44c657328db4a71bfcdae3dd84400a12025-08-20T02:08:08ZengNature Publishing GroupBlood Cancer Journal2044-53852025-04-011511510.1038/s41408-025-01258-0Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trialFieke W. Hoff0Ying Huang1Rina Li Welkie2Ronan T. Swords3Elie Traer4Eytan M. Stein5Tara L. Lin6Prapti A. Patel7Robert H. Collins8Maria R. Baer9Vu H. Duong10William G. Blum11Martha L. Arellano12Wendy Stock13Olatoyosi Odenike14Robert L. Redner15Tibor Kovacsovics16Michael W. Deininger17Joshua F. Zeidner18Rebecca L. Olin19Catherine C. Smith20James M. Foran21Gary J. Schiller22Emily K. Curran23Kristin L. Koenig24Nyla A. Heerema25Timothy Chen26Molly Martycz27Mona Stefanos28Sonja G. Marcus29Leonard Rosenberg30Brian J. Druker31Ross L. Levine32Amy Burd33Ashley O. Yocum34Uma M. Borate35Alice S. Mims36John C. Byrd37Yazan F. Madanat38Department of Internal Medicine, University of Texas Southwestern Medical CenterDepartment of Medicine, The Ohio State UniversityDepartment of Medicine, The Ohio State UniversityDivision of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science UniversityDivision of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science UniversityDepartment of Medicine, Memorial Sloan Kettering Cancer CenterDepartment of Internal Medicine, University of Kansas Medical CenterServier Pharmaceuticals, LLCDepartment of Internal Medicine, University of Texas Southwestern Medical CenterDepartment of Medicine, University of Maryland Greenebaum Comprehensive Cancer CenterDepartment of Medicine, University of Maryland Greenebaum Comprehensive Cancer CenterDepartment of Hematology and Medical Oncology, Winship Cancer Institute of Emory UniversityDepartment of Hematology and Medical Oncology, Winship Cancer Institute of Emory UniversityDepartment of Medicine, University of ChicagoDepartment of Medicine, University of ChicagoDepartment of Medicine, UPMC Hillman Cancer CenterDivision of Hematology and Hematologic Malignancies, The University of UtahDepartment of Internal Medicine, Versiti Blood Research Institute and Medical College of WisconsinDivision of Hematology, Lineberger Comprehensive Cancer Center, University of North CarolinaDepartment of Medicine, University of California, San FranciscoDepartment of Medicine, University of California, San FranciscoDepartment of Internal, Medicine Mayo ClinicDepartment of Medicine, David Geffen School of Medicine at University of California, Los AngelesDepartment of Internal Medicine, University of CincinnatiDepartment of Medicine, The Ohio State UniversityDepartment of Medicine, The Ohio State UniversityDepartment of Medicine, The Ohio State UniversityDepartment of Medicine, The Ohio State UniversityDepartment of Medicine, The Ohio State UniversityLeukemia and Lymphoma SocietyLeukemia and Lymphoma SocietyDivision of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science UniversityDepartment of Medicine, Memorial Sloan Kettering Cancer CenterDepartment of Internal Medicine, University of CincinnatiLeukemia and Lymphoma SocietyDepartment of Medicine, The Ohio State UniversityDepartment of Medicine, The Ohio State UniversityDepartment of Internal Medicine, University of CincinnatiDepartment of Internal Medicine, University of Texas Southwestern Medical Centerhttps://doi.org/10.1038/s41408-025-01258-0 |
| spellingShingle | Fieke W. Hoff Ying Huang Rina Li Welkie Ronan T. Swords Elie Traer Eytan M. Stein Tara L. Lin Prapti A. Patel Robert H. Collins Maria R. Baer Vu H. Duong William G. Blum Martha L. Arellano Wendy Stock Olatoyosi Odenike Robert L. Redner Tibor Kovacsovics Michael W. Deininger Joshua F. Zeidner Rebecca L. Olin Catherine C. Smith James M. Foran Gary J. Schiller Emily K. Curran Kristin L. Koenig Nyla A. Heerema Timothy Chen Molly Martycz Mona Stefanos Sonja G. Marcus Leonard Rosenberg Brian J. Druker Ross L. Levine Amy Burd Ashley O. Yocum Uma M. Borate Alice S. Mims John C. Byrd Yazan F. Madanat Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial Blood Cancer Journal |
| title | Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial |
| title_full | Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial |
| title_fullStr | Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial |
| title_full_unstemmed | Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial |
| title_short | Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial |
| title_sort | molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older a report from the beat aml clinical trial |
| url | https://doi.org/10.1038/s41408-025-01258-0 |
| work_keys_str_mv | AT fiekewhoff molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT yinghuang molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT rinaliwelkie molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT ronantswords molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT elietraer molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT eytanmstein molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT tarallin molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT praptiapatel molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT roberthcollins molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT mariarbaer molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT vuhduong molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT williamgblum molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT marthalarellano molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT wendystock molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT olatoyosiodenike molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT robertlredner molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT tiborkovacsovics molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT michaelwdeininger molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT joshuafzeidner molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT rebeccalolin molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT catherinecsmith molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT jamesmforan molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT garyjschiller molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT emilykcurran molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT kristinlkoenig molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT nylaaheerema molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT timothychen molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT mollymartycz molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT monastefanos molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT sonjagmarcus molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT leonardrosenberg molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT brianjdruker molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT rossllevine molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT amyburd molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT ashleyoyocum molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT umamborate molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT alicesmims molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT johncbyrd molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial AT yazanfmadanat molecularcharacterizationofnewlydiagnosedacutemyeloidleukemiapatientsaged60yearsorolderareportfromthebeatamlclinicaltrial |